6-chloro-N2,N3-bis(4-(trifluoromethoxy)phenyl)quinoxaline-2,3-diamine

ID: ALA4552349

PubChem CID: 155554748

Max Phase: Preclinical

Molecular Formula: C22H13ClF6N4O2

Molecular Weight: 514.81

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  FC(F)(F)Oc1ccc(Nc2nc3ccc(Cl)cc3nc2Nc2ccc(OC(F)(F)F)cc2)cc1

Standard InChI:  InChI=1S/C22H13ClF6N4O2/c23-12-1-10-17-18(11-12)33-20(31-14-4-8-16(9-5-14)35-22(27,28)29)19(32-17)30-13-2-6-15(7-3-13)34-21(24,25)26/h1-11H,(H,30,32)(H,31,33)

Standard InChI Key:  HGMVEILKIFNYRF-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 35 38  0  0  0  0  0  0  0  0999 V2000
   34.7350  -21.0780    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.5923  -21.0791    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   36.1625  -19.4186    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   34.0213  -19.8377    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.7331  -19.4249    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.1602  -21.0755    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   34.0201  -20.6651    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.5956  -19.4253    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   36.8801  -19.8361    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.4485  -19.8341    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.4473  -20.6625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.8789  -20.6645    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.5975  -18.6082    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.3076  -18.2067    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.3099  -17.3903    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.6026  -16.9791    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.8916  -17.3904    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.8928  -18.2055    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.3135  -19.4293    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   37.6035  -16.1620    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   38.3117  -15.7541    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.3125  -14.9369    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   39.0189  -16.1635    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   39.0147  -15.3409    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   37.5900  -21.8963    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.8804  -22.3011    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.8777  -23.1175    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.5848  -23.5289    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.2960  -23.1179    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.2952  -22.3028    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.5836  -24.3461    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   38.2907  -24.7557    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.2895  -25.5729    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   38.9990  -24.3482    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   38.9941  -25.1637    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  9  8  1  0
  6 12  2  0
 12  9  1  0
 10 11  1  0
 12  2  1  0
 10  5  2  0
  7  1  1  0
  5  4  1  0
  1 11  2  0
 11  6  1  0
  9  3  2  0
  4  7  2  0
 10  3  1  0
  8 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 13  1  0
  4 19  1  0
 16 20  1  0
 20 21  1  0
 21 22  1  0
 21 23  1  0
 21 24  1  0
  2 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 29  1  0
 29 30  2  0
 30 25  1  0
 28 31  1  0
 31 32  1  0
 32 33  1  0
 32 34  1  0
 32 35  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4552349

    ---

Associated Targets(Human)

NCI-H1703 (410 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NCI-H226 (44470 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NCI-H358 (882 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 514.81Molecular Weight (Monoisotopic): 514.0631AlogP: 7.57#Rotatable Bonds: 6
Polar Surface Area: 68.30Molecular Species: NEUTRALHBA: 6HBD: 2
#RO5 Violations: 2HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski): 2
CX Acidic pKa: CX Basic pKa: 1.48CX LogP: 8.83CX LogD: 8.83
Aromatic Rings: 4Heavy Atoms: 35QED Weighted: 0.26Np Likeness Score: -1.03

References

1.  (2017)  Aryl amine substituted quinoxaline used as anticancer drugs, 

Source